Showing results (71-80 of 108) with videos related to
Sort By:
Pageof 11
Journal for Immunotherapy of Cancer|January 2, 2024
Discovery of U2AF1 neoantigens in myeloid neoplasmsMelinda Ann Biernacki, Jessica Lok, Ralph Graeme Black, et al.The British Journal of Dermatology|February 8, 2019
Peak Pruritus Numerical Rating Scale: psychometric validation and responder definition for assessing itch in moderate-to-severe atopic dermatitisG Yosipovitch, M Reaney, V Mastey, et al.Pediatric Blood & Cancer|August 12, 2016
miR-155 expression and correlation with clinical outcome in pediatric AML: A report from Children's Oncology GroupRanjani Ramamurthy, Maya Hughes, Valerie Morris, et al.Leukemia|August 20, 2024
Efficacy and safety of bosutinib in previously treated patients with chronic myeloid leukemia: final results from the BYOND trialCarlo Gambacorti-Passerini, Tim H Brümmendorf, Elisabetta Abruzzese, et al.Nature Communications|January 5, 2018
A machine learning approach to integrate big data for precision medicine in acute myeloid leukemiaSu-In Lee, Safiye Celik, Benjamin A Logsdon, et al.JAMA Oncology|May 9, 2024
Dose-Adjusted EPOCH Plus Inotuzumab Ozogamicin in Adults With Relapsed or Refractory B-Cell ALL: A Phase 1 Dose-Escalation TrialNoam E Kopmar, Kim Quach, Ted A Gooley, et al.The Lancet. Haematology|December 22, 2015
Treatment with PF-04449913, an oral smoothened antagonist, in patients with myeloid malignancies: a phase 1 safety and pharmacokinetics studyGiovanni Martinelli, Vivian G Oehler, Cristina Papayannidis, et al.Nature Genetics|February 4, 2014
Lis1 regulates asymmetric division in hematopoietic stem cells and in leukemiaBryan Zimdahl, Takahiro Ito, Allen Blevins, et al.Blood|July 24, 2009
The preferentially expressed antigen in melanoma (PRAME) inhibits myeloid differentiation in normal hematopoietic and leukemic progenitor cellsVivian G Oehler, Katherine A Guthrie, Carrie L Cummings, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 1, 2005
Randomized trial of allogeneic related bone marrow transplantation versus peripheral blood stem cell transplantation for chronic myeloid leukemiaVivian G Oehler, Jerald P Radich, Barry Storer, et al.Pageof 11